| Generic Name | Brand Name |
|---|---|
| clomiphene citrate | Clomid, Milophene, Serophene |
Clomiphene stimulates the release of hormones needed to cause ovulation.
Clomiphene therapy is typically used for 5 consecutive days early in the menstrual cycle, for 3 to 6 monthly cycles. It may take several cycles to find the right dose to stimulate ovulation. After that dose is determined, a woman will take the drug for at least 3 more cycles. If she does not become pregnant after 6 cycles, it is unlikely that further clomiphene treatment will be successful.
For women. Clomiphene may be prescribed to:
Clomiphene is sometimes used together with other medicines and infertility treatments.
Before trying clomiphene, women with polycystic ovary syndrome (PCOS) who are overweight are advised to lower their body mass index (BMI) with diet and exercise. Reaching a healthy weight can restart ovulation.1 If that isn't successful, using medicine to correct insulin metabolism may start ovulation. If not, a combination of medicines may help stimulate ovulation.
For men. Clomiphene may be used to treat low sperm counts (oligospermia).
Unexplained infertility. There is limited evidence that clomiphene makes pregnancy more likely for couples with unexplained infertility.3 Clomiphene may be most effective when it is used to generate multiple eggs before an insemination procedure.
Infrequent or no ovulation. Of women whose infertility is caused only by absent or infrequent ovulation, with clomiphene treatment approximately 80% will ovulate. And within 9 cycles of treatment, 70% to 75% will become pregnant. Experts used to think miscarriage rates were slightly higher in women who became pregnant using clomiphene. But recent studies have not shown this to be true.2
Polycystic ovary syndrome. Clomiphene alone may not be an effective treatment for most women with polycystic ovary syndrome (PCOS) and severe insulin resistance, which is closely linked to obesity. Women with PCOS who are overweight often begin ovulating when they reduce their body mass index (BMI) with diet and exercise.
Side effects of clomiphene include:
Women who become pregnant after clomiphene therapy have an approximately 5% to 8% chance of multiple pregnancy.2 This compares to a 1% to 2% chance in the general North American and European population.3 Multiples resulting from clomiphene treatment are almost exclusively twins. Triplets are rare.2
In some studies, miscarriage rates are slightly higher in women who become pregnant using clomiphene. It is not clear if this is related to an early hormonal effect on the egg or to preexisting conditions such as age or polycystic ovary syndrome, which are found more often in women who take clomiphene. Other studies have not shown an increased miscarriage rate.2
Clomiphene has not been observed to harm the fetus.
See Drug Reference for a full list of side effects. (Drug Reference is not available in all systems.)
Many women try clomiphene therapy before beginning a series of infertility tests. But most doctors recommend a careful medical history, physical exam, and semen analysis before beginning clomiphene. If your pituitary, thyroid, and adrenal function have been checked, you have no signs of endometriosis, and your partner's fertility has been confirmed, clomiphene is considered a safe and simple option.
Most women who become pregnant by using clomiphene do so within 3 cycles, and the majority become pregnant within 6 cycles of clomiphene use.1 Prolonged treatment with clomiphene is usually not helpful. After 3 to 6 cycles, further evaluation or a change in treatment plan is recommended.
Make sure your doctor knows of any abnormal vaginal bleeding or history of problem ovarian cysts before prescribing clomiphene for you.
Complete the new medication information form (PDF)(What is a PDF document?) to help you understand this medication.
Citations
- American College of Obstetricians and Gynecologists (2002, reaffirmed 2008). Management of infertility caused by ovulatory dysfunction. ACOG Practice Bulletin No. 34. Obstetrics and Gynecology, 99(2): 347–358.
- Speroff L, Fritz MA (2005). Induction of ovulation. In Clinical Gynecologic Endocrinology and Infertility, 7th ed., pp. 1175–1213. Philadelphia: Lippincott Williams and Wilkins.
- Al-Inany H (2005). Female infertility, search date April 2004. Online version of BMJ Clinical Evidence. Also available online: http://www.clinicalevidence.com.
Last Revised: March 19, 2010
Author: Healthwise Staff
Medical Review: Sarah Marshall, MD - Family Medicine & Femi Olatunbosun, MB, FRCSC - Obstetrics and Gynecology
This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.
To learn more visit Healthwise.org
© 1995-2011 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
Seton is proud to have four hospitals – the only hospitals in Central Texas - that have earned the Magnet designation, the highest award for nursing excellence given by the American Nurses Association.
